Qingjun He

820 total citations
18 papers, 610 citations indexed

About

Qingjun He is a scholar working on Molecular Biology, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Qingjun He has authored 18 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Complementary and alternative medicine. Recurrent topics in Qingjun He's work include Natural product bioactivities and synthesis (5 papers), Natural Compounds in Disease Treatment (5 papers) and Cancer-related molecular mechanisms research (4 papers). Qingjun He is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Natural Compounds in Disease Treatment (5 papers) and Cancer-related molecular mechanisms research (4 papers). Qingjun He collaborates with scholars based in China and United States. Qingjun He's co-authors include Shuzhong Cui, Quanxing Liao, Ziying Lei, Xianzi Yang, Lisi Zeng, Zhen Tang, Tiantian Cheng, Jun Chi, Hong Zhang and Shao‐Jiang Song and has published in prestigious journals such as IEEE Transactions on Industrial Electronics, Molecular Cancer and Journal of Natural Products.

In The Last Decade

Qingjun He

18 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingjun He China 11 390 334 113 51 50 18 610
Jinghua Gu United States 12 305 0.8× 156 0.5× 81 0.7× 87 1.7× 41 0.8× 33 541
Lixin Yang China 11 216 0.6× 167 0.5× 57 0.5× 61 1.2× 37 0.7× 18 459
Xinlan Lu China 17 487 1.2× 368 1.1× 141 1.2× 88 1.7× 9 0.2× 40 790
Zhao Wu China 13 350 0.9× 96 0.3× 46 0.4× 131 2.6× 32 0.6× 38 638
Tengxiang Chen China 12 294 0.8× 181 0.5× 43 0.4× 70 1.4× 38 0.8× 48 516
Kezhen Lv China 13 396 1.0× 285 0.9× 56 0.5× 169 3.3× 8 0.2× 15 654
Liansheng Gong China 14 306 0.8× 235 0.7× 68 0.6× 112 2.2× 5 0.1× 29 519
Yongping Zhou China 15 257 0.7× 218 0.7× 113 1.0× 205 4.0× 8 0.2× 38 628
Sifeng Tao China 11 371 1.0× 210 0.6× 46 0.4× 92 1.8× 6 0.1× 16 645
Dajian Zhu China 13 239 0.6× 120 0.4× 63 0.6× 194 3.8× 11 0.2× 25 525

Countries citing papers authored by Qingjun He

Since Specialization
Citations

This map shows the geographic impact of Qingjun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjun He more than expected).

Fields of papers citing papers by Qingjun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingjun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjun He. The network helps show where Qingjun He may publish in the future.

Co-authorship network of co-authors of Qingjun He

This figure shows the co-authorship network connecting the top 25 collaborators of Qingjun He. A scholar is included among the top collaborators of Qingjun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingjun He. Qingjun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
He, Qingjun, et al.. (2023). MicroRNA3650 Promotes Gastric Cancer Proliferation and Migrationthrough the PTEN/PI3K-AKT-mTOR and Hippo Pathways. Protein and Peptide Letters. 30(11). 966–973. 1 indexed citations
2.
Zhao, Wenxiang, Qingjun He, Wei Tian, Yuhua Sun, & Jinghua Ji. (2023). Investigation of Winding Configuration on Electromagnetic Vibration in Modular Dual Three-Phase PM Machine. IEEE Transactions on Industrial Electronics. 71(2). 1257–1267. 13 indexed citations
3.
Zhou, Le, Ming Bai, Qingjun He, et al.. (2022). Nine new dihydro-β-agarofuran sesquiterpene polyesters from the leaves of Tripterygium wilfordii. New Journal of Chemistry. 46(5). 2423–2430. 4 indexed citations
4.
Yang, Xianzi, et al.. (2021). High miR-3650 expression in nasopharyngeal carcinoma and its clinical prognostic values. Pathology - Research and Practice. 224. 153506–153506. 3 indexed citations
5.
Zeng, Lisi, Quanxing Liao, Xianzi Yang, et al.. (2021). Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids. Cancer Biology and Medicine. 18(3). 750–762. 20 indexed citations
7.
Zhou, Le, Qingjun He, Liwei Lu, et al.. (2020). Discovery of dihydro-β-agarofurans from Tripterygium wilfordii with their H2O2-induced SH-SY5Y cell protective effects. Bioorganic Chemistry. 104. 104247–104247. 7 indexed citations
8.
Zhao, Peng, Bin Lin, Le Zhou, et al.. (2020). Dihydro-β-agarofuran sesquiterpenoid derivatives with neuroprotective activity from the leaves of Tripterygium wilfordii. Fitoterapia. 142. 104501–104501. 8 indexed citations
9.
Lei, Ziying, Jiahong Wang, Zhi Li, et al.. (2020). Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study. Chinese Journal of Cancer Research. 32(6). 794–803. 16 indexed citations
10.
Lei, Ziying, Yue Wang, Jiahong Wang, et al.. (2020). Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer. JAMA Network Open. 3(8). e2013940–e2013940. 59 indexed citations
11.
He, Qingjun, Le Zhou, Liwei Lu, et al.. (2019). Dihydro-β-agarofuran sesquiterpenoid derivatives with anti-inflammatory activity from the leaves of Tripterygium wilfordii. Bioorganic Chemistry. 92. 103288–103288. 13 indexed citations
12.
Li, Junying, Yali Ji, Jiang Liu, et al.. (2019). Impacts of cigarette smoking on liver fibrosis and its regression under therapy in male patients with chronic hepatitis B. Liver International. 39(8). 1428–1436. 10 indexed citations
13.
Li, Junying, Yali Ji, Jiang Liu, et al.. (2019). Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection. Clinical and Translational Gastroenterology. 10(10). e00085–e00085. 17 indexed citations
14.
Zhou, Le, Qingjun He, Liwei Lu, et al.. (2019). Tripterfordins A–O, Dihydro-β-agarofuran Sesquiterpenoids from the Leaves of Tripterygium wilfordii. Journal of Natural Products. 82(10). 2696–2706. 9 indexed citations
15.
Zeng, Lisi, Quanxing Liao, Zhaowei Zou, et al.. (2018). Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1221–1236. 49 indexed citations
16.
Yang, Xianzi, Qingjun He, Tiantian Cheng, et al.. (2018). Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma. Cellular Physiology and Biochemistry. 48(1). 251–262. 20 indexed citations
17.
Yang, Xianzi, Tiantian Cheng, Qingjun He, et al.. (2018). LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Molecular Cancer. 17(1). 126–126. 310 indexed citations
18.
He, Qingjun, Bin Lin, Pinyi Gao, et al.. (2016). Secondary metabolites from the flower buds of Lonicera japonica and their in vitro anti-diabetic activities. Fitoterapia. 110. 44–51. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026